Press Releases

Cystic Fibrosis drug added to Ontario Drug Benefit Formulary



(September 24, 2021) Simcoe-Grey MPP Jim Wilson is pleased to congratulate the Cystic Fibrosis community on the success of its years-long battle to have the life-altering medication Trikafta made available to Ontario’s CF patients. 


Health Minister Christine Elliott announced today that Trikafta has been added to the Ontario Drug Benefit Formulary. It joins Orkambi and Kalydeco, two other recently funded CF drugs. These transformational medications improve life quality and extend the lives of people living with Cystic Fibrosis.


“Much of the credit for this process goes to families in our region who brought this issue to my attention eight years ago and have lead the charge every step of the way,” said Wilson. “People like Beth and Madi Vanstone, and Sasha Haughian and Jamie Larocque, have been tireless in their efforts to access these innovative drugs and they have become true advocates in their own right.” 


“I also want to wholeheartedly thank our Health Minister Christine Elliott for making this momentous announcement,” continued Wilson. “Without her and the Ford government I do not believe we would be where we are. They deserve full recognition.”


Today’s announcement comes after complex drug approval and reimbursement processes involving both federal and provincial governments. The province’s approval is the last step. It means that doctors can now prescribe Trikafta for people aged 12 and up with cystic fibrosis and that the medication will be funded under Ontario’s publically funded drug programs. 


MPP Wilson is pleased to see the issue has finally found resolution. He has raised the question of Cystic Fibrosis medication availability numerous times in the Ontario Legislature for close to a decade. 


See today’s Government of Ontario News Release HERE.




Media in Simcoe-Grey were quick to pick up on the latest Trikafta developments.  You can read the account here.  Collingwood Today published this story.



Ontario's Debt Clock

Email Signup


Get the most up to date information on the 2019 Novel Coronavirus (COVID-19).